Serum selenium in head and neck cancer patients - A new marker of tumor activity?

Anticancer Research

Volumn 25, Issue 3 A, 2005, Pages 1711-1712

  Büntzel, Jens ^a,g   Micke, Oliver ^b   Glatzel, Michael ^c   Fröhlich, Dietmar ^c   Bruns, Frank ^d   Mücke, Ralph ^e   Schönekaes, Klaus G ^f  

^a Department of Otolaryngology Head Neck Surgery   (Germany)

^b UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^c Zentralklinikum Suhl ^*  (Germany)

^d HANNOVER MEDICAL SCHOOL   (Germany)

^e ST JOSEFS HOSPITAL   (Germany)

^f KLINIKUM MINDEN   (Germany)

^g Südharzkrankenhaus Nordhausen gGmbh   (Germany)

Author keywords

Head and neck cancer; Resectability; Serum selenium

Indexed keywords

GLUTATHIONE PEROXIDASE; MALONALDEHYDE; SELENIUM; TUMOR MARKER;

ADULT; ADVANCED CANCER; ATOMIC ABSORPTION SPECTROMETRY; CANCER DIAGNOSIS; CONCENTRATION RESPONSE; CONFERENCE PAPER; DIAGNOSTIC VALUE; DISEASE MARKER; ENZYME ACTIVITY; FEMALE; HEAD AND NECK CANCER; HUMAN; HUMAN TISSUE; HYPOPHARYNX CANCER; LARYNX CANCER; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; OROPHARYNX CANCER; PRIORITY JOURNAL; TREATMENT PLANNING; TUMOR VOLUME;

HEAD AND NECK NEOPLASMS; HUMANS; SELENIUM; SPECTROPHOTOMETRY, ATOMIC; TUMOR MARKERS, BIOLOGICAL;

EID: 21244504627     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (10)

1. Mücke R, Büntzel J, Schönekaes KG, Micke O, Glatzel M, Kisters K and Bruns F: Selen in der Onkologie - Möglichkeiten und Grenzen. Im Focus Onkologie 5(2): 77-80, 2002.
2. Büntzel J, Glatzel M, Micke O and Fröhlich D: Status of essential trace elements in untreated carcinomas of the head and neck, Laryngo Rhino Otol 82(8): 573-577, 2003.
3. Schrauzer GN: Selen: Neue Entwicklungen aus der Biologie, Biochemie und Medizin, 3. Aufl. Heidelberg, Leipzig, Johann Ambrosius Barth, 1998.
4. Micke O, Bruns F, Schäfer U, Horst E, Büntzel J and Willich N: The clinical value of squamous cell carcinoma antigen in patients irradiated for locally advanced cancer of the head and neck. Anticancer Res 23: 907-912, 2003.
5. Jayadeep A, Raveendran Pillai K, Kannan S, Nalinakumari KR, Mathew B, Krishnan Nair M and Menon VP: Serum levels of copper, zinc, iron and ceruloplasmin in oral leukoplakia and squamous cell carcinoma. J Exp Clin Cancer Res 16(3): 295-300, 1997.
6. Prasad AS, Kaplan J, Beck FW, Penny HS, Shamsa FH, Salwen WA, Marks SC and Mathog RH: Trace elements in head and neck cancer patients: zinc status and immunologic functions. Otolaryngol Head Neck Surg 116(6 Pt 1): 624-629, 1997.
7. Yadav SP, Gera A, Singh I and Chanda R: Serum selenium levels in patients with head and neck cancer. J Otolaryngol 31(4): 216-219, 2002.
8. Zhou B, Lu S, Chen X, He D and Yuan H: Study on some metal elements levels and the T lymphocyte subset of the peripheral lymphocytes in patients with nasopharyngeal carcinomas. Lin Chuang Er Bi Yan Hou Ke Za Zhi 15(11): 503-504, 2001.
9. Kiremedjian-Schumacher L and Roy M: Effect of selenium on the immunocompetence of patients with head and neck cancer on adoptive immunotherapy of early and established lesions. Biofactors 14: 161-168, 2001.
10. Last KW, Cornezius V, Delves T, Sieniawaska C, Fitzgibbon J, Norton A, Amess J, Wilson A, Rohatiner AZS and Lister TA: Presentation serum selenium predicts for overall survival, dose delivery, and first treatment response in aggressive non-Hodgkin's-lymphoma. J Clin Oncol 21: 2335-2341, 2003.